ST8SIA6 and prostate carcinoma: We also evaluated the impact of ST8SIA6-AS1 knockdown on the malignant phenotype of prostate cancer cells, including their proliferation, migration, and invasion capabilities, to estimate its potential as a therapeutic target for prostate cancer.